Laparoscopic cytoreduction for primary advanced ovarian cancer

We evaluated the feasibility of laparoscopic cytoreduction for primary advanced ovarian cancer. All patients with presumed stage 3/4 primary ovarian cancer underwent attempted laparoscopic cytoreduction. All patients had CT evidence of omental metastasis and ascites. A 5-port (5-mm) transperitoneal...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the Society of Laparoendoscopic Surgeons 2010-01, Vol.14 (1), p.80-82
Main Authors: Fanning, James, Hojat, Rod, Johnson, Jil, Fenton, Bradford
Format: Article
Language:English
Subjects:
Aged
Feasibility Studies
Female
Gynecologic Surgical Procedures - methods
Humans
Hysterectomy
Laparoscopy - methods
Laser Coagulation
Middle Aged
Ovarian Neoplasms - pathology
Ovarian Neoplasms - surgery
Ovariectomy - methods
Scientific Papers
Treatment Outcome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We evaluated the feasibility of laparoscopic cytoreduction for primary advanced ovarian cancer. All patients with presumed stage 3/4 primary ovarian cancer underwent attempted laparoscopic cytoreduction. All patients had CT evidence of omental metastasis and ascites. A 5-port (5-mm) transperitoneal approach was used. A bilateral salpingo-oophorectomy, supracervical hysterectomy, and omentectomy were performed with PlasmaKinetic (PK) cutting forceps. A laparoscopic 5-mm Argon-Beam Coagulator was used to coagulate tumor in the pelvis, abdominal peritoneum, intestinal mesentery, and diaphragm. Nine of 11 cases (82%) were successfully debulked laparoscopically without conversion to laparotomy. Median operative time was 2.5 hours, and median blood loss was 275 mL. All tumors were debulked to
ISSN:1086-8089
1938-3797
DOI:10.4293/108680810X12674612014707